Dang A Q, Faas F H, Carter W J
Lipids. 1984 Aug;19(8):578-82. doi: 10.1007/BF02534714.
Streptozotocin-induced diabetes significantly decreased rat liver microsomal long-chain fatty acyl-CoA (LCA-CoA) hydrolase. The decrease was observed using either palmitoyl-CoA (35 per cent, p less than 0.01) or oleoyl-CoA (23 per cent, p less than 0.01) as the substrate for the enzyme. Under the same conditions, diabetes did not significantly alter activity of LCA-CoA synthetase. Daily subcutaneous injections of protamine zinc insulin (10-12 units/day) into the diabetic rats returned their blood glucose to normal but only partially corrected the LCA-CoA hydrolase activity and did not effect LCA-CoA synthetase activity. The decreased LCA-CoA hydrolase and the unchanged LCA-CoA synthetase activities in the diabetic rat liver were interpreted as factors that may contribute to elevation of fatty acyl-CoA levels in the diabetic liver.
链脲佐菌素诱导的糖尿病显著降低了大鼠肝脏微粒体长链脂肪酰辅酶A(LCA-CoA)水解酶的活性。以棕榈酰辅酶A(降低35%,p<0.01)或油酰辅酶A(降低23%,p<0.01)作为该酶的底物时,均观察到了这种降低。在相同条件下,糖尿病并未显著改变LCA-CoA合成酶的活性。每天给糖尿病大鼠皮下注射精蛋白锌胰岛素(10 - 12单位/天)可使它们的血糖恢复正常,但只能部分纠正LCA-CoA水解酶的活性,且对LCA-CoA合成酶的活性没有影响。糖尿病大鼠肝脏中LCA-CoA水解酶活性降低而LCA-CoA合成酶活性不变,这被认为可能是导致糖尿病肝脏中脂肪酰辅酶A水平升高的因素。